Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
325.10
+4.19 (1.31%)
Oct 27, 2025, 1:05 PM EDT - Market open
Insulet Revenue
Insulet had revenue of $649.10M in the quarter ending June 30, 2025, with 32.88% growth. This brings the company's revenue in the last twelve months to $2.36B, up 25.99% year-over-year. In the year 2024, Insulet had annual revenue of $2.07B with 22.07% growth.
Revenue (ttm)
$2.36B
Revenue Growth
+25.99%
P/S Ratio
9.55
Revenue / Employee
$605,000
Employees
3,900
Market Cap
22.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.07B | 374.50M | 22.07% |
| Dec 31, 2023 | 1.70B | 391.80M | 30.02% |
| Dec 31, 2022 | 1.31B | 206.50M | 18.79% |
| Dec 31, 2021 | 1.10B | 194.40M | 21.49% |
| Dec 31, 2020 | 904.40M | 166.20M | 22.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PODD News
- 4 days ago - 10 stocks primed for growth in the S&P 500's cheapest sectors - Market Watch
- 4 days ago - Insulet Announces Appointment of Robert L. Huffines to its Board of Directors - Business Wire
- 17 days ago - Insulet to Host Investor Day on November 20, 2025 - Business Wire
- 5 weeks ago - These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process - Market Watch
- 5 weeks ago - Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette - Business Wire
- 5 weeks ago - Medical device maker Insulet names industry veteran Flavia Pease as CFO - Reuters
- 5 weeks ago - Insulet Announces CFO Transition - Business Wire
- 6 weeks ago - Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha